About 13,145 results

FDA approves CSL's gene therapy for hemophilia

Nov 22nd, 2022 - Nov 22 (Reuters) - The U.S. health regulator on Tuesday approved Australian drugmaker CSL Ltd and partner Uniqure NV’s gene therapy for hemophilia B, potentially offering a long-term solution for patients with the blood clotting disorder. The approval from the Food and Drug Administration makes the treatment, which will be branded Hemgenix, the first gene therapy for the rare inherited disorder...

US STOCKS-Retailer, energy boost helps Wall Street rally

Nov 22nd, 2022 - (For a Reuters live blog on U.S., UK and European stock markets, click or type LIVE/ in a news window.) Best Buy up, sees smaller annual sales drop Dollar Tree drops on lower FY profit forecast Manchester United surges on sale report (Updates to market close) NEW YORK, Nov 22 (Reuters) - U.S. stocks rallied on Tuesday in light trading volume as a sales forecast by Best Buy dampened concerns hig...

Updated COVID vaccines offer better protection than original -U.S. study

Nov 22nd, 2022 - Nov 22 (Reuters) - Updated COVID-19 boosters offer increased protection against new variants in people who have previously received up to four doses of the older vaccine, a real-world study in the United States showed. The study of over 360,000 people, published in Morbidity and Mortality Weekly Report, offers the first evidence that the new vaccines by Pfizer-BioNTech and Moderna provide bette...

Gavi says it is not in breach of Novavax vaccine deal

Nov 22nd, 2022 - Nov 22 (Reuters) - Global vaccine alliance Gavi said on Tuesday it was not in breach of a deal to buy Novavax’s COVID-19 vaccine and that it reserved all rights, including the recovery of advance payments to the company. Novavax said on Monday it delivered a notice to Gavi to terminate the COVID-19 vaccine sale agreement with immediate effect, citing the alliance’s failure to procure the 350 mi...

US STOCKS-Futures flat after slipping on China lockdown worries

Nov 22nd, 2022 - (For a Reuters live blog on U.S., UK and European stock markets, click or type LIVE/ in a news window.) Futures: Dow up 0.09%, S&P up 0.08%, Nasdaq down 0.04% Nov 22 (Reuters) - U.S. stock index futures were trading flat on Tuesday after starting the week lower due to worries around stricter COVID-19 curbs in China, while drawing comfort from less-hawkish comments on interest-rate hikes from po...

SPECIAL REPORT-Gender imbalance emerges among trans teens seeking treatment

Nov 18th, 2022 - (For more Reuters Special Reports, click on) Nov 18 (Reuters) - A year after moving to Bridge City, Texas, 8-year-old Samuel Kulovitz thought his life couldn’t get any worse. He had made no friends in the swampy oil refinery town and spent most of his time in his family’s mobile home. He missed Florida and playing on the beach there with other children. But life did get worse. He hit puberty. F...

REFILE-FEATURE -As Texas cracks down on trans youth, some families feel trapped

Nov 11th, 2022 - (Clarifies that a website for trans children in Texas was not created solely by Equality Texas, but a number of groups) Governor deems trans youth medical care child abuse LGBTQ+ families mull leaving state after February decree Nearly 30,000 trans teens aged 13-17 live in Texas By Sydney Bauer AUSTIN, Texas, Nov 11 (Thomson Reuters Foundation) - E very morning, Mary’s eight-year-old daughter P...

Daimler Truck: "The supply chain is somehow broken"

Nov 11th, 2022 - BERLIN, Nov 11 (Reuters) - Daimler Truck said that while the chip shortage was easing, underinvestment by small suppliers during the coronavirus pandemic meant a broad range of parts were still lacking as demand for trucks bounced back. “Overall the supply chain is somehow broken,” Chief Financial Officer Jochen Goetz said on an analyst call on Friday. “The market picked up super quickly... the...

Novavax cuts full-year revenue forecast

Nov 8th, 2022 - Nov 8 (Reuters) - Novavax Inc cut its full-year revenue forecast on Tuesday, hurt by a global supply glut in COVID-19 vaccine and waning demand. The company now expects annual revenue to be about $2 billion, the lower end of its prior forecast range of between $2 billion and $2.3 billion. In August, Novavax halved its full-year revenue forecast as it did not expect further sales of its COVID-19...

EU antitrust regulators to probe Microsoft's $69 bln Activision bid

Nov 8th, 2022 - BRUSSELS, Nov 8 (Reuters) - EU antitrust regulators on Tuesday opened a full-scale investigation into Microsoft’s $69 billion bid for “Call of Duty” maker Activision Blizzard, warning the deal may hurt competition. The U.S. software company, which announced the deal in January, is betting Activision’s stable of games will help it compete better with leaders Tencent and Sony, with the latter bei...


Nov 2nd, 2022 - Here are the top stories and upcoming coverage plans for Reuters text service as of 6:00 a.m. GMT/2:00 p.m. SGT. For a full schedule of news and events, go to our editorial calendar on Reuters Connect. North Korea missile lands off South Korean coast for first time; South responds with own launches SEOUL, Nov 2 (Reuters) - A North Korean ballistic missile landed less than 60 kilometres off Sout...

Australia's CSL in mRNA vaccine licensing deal with Arcturus

Nov 1st, 2022 - Nov 2 (Reuters) - Australia’s CSL Ltd on Wednesday entered into a collaboration and license agreement with Arcturus Therapeutics Holdings Inc to access the U.S. drug developer’s late stage self-amplifying mRNA vaccine platform technology. The biopharmaceutical firm said it would pay Arcturus $200 million upfront in return for exclusive licence to its next generation mRNA technology to develop v...

REFILE-J&J to buy Abiomed in $16.6 bln deal

Nov 1st, 2022 - (Corrects spelling of company in first paragraph) Nov 1 (Reuters) - Johnson & Johnson said on Tuesday it will acquire medical technology provider Abiomed Inc for an upfront payment of $380 per share in cash, corresponding to an enterprise value of nearly $16.6 billion. (Reporting by Raghav Mahobe in Bengaluru; Editing by Shounak Dasgupta)

Eli Lilly cuts annual profit forecast

Nov 1st, 2022 - Nov 1 (Reuters) - Drugmaker Eli Lilly and Co cut its full-year profit forecast on Tuesday, as a stronger dollar piled more pressure on the drugmaker struggling with lower insulin prices and generic competition for its cancer drug. The company now expects adjusted full-year earnings of $7.70 to $7.85 per share, from its prior forecast of $7.90 to $8.05.

Foxconn raises daily bonuses for some staff at Zhengzhou plant in China

Nov 1st, 2022 - BEIJING, Nov 1 (Reuters) - Apple iPhone maker Foxconn said on Tuesday that daily bonuses for some of its staff at its Zhengzhou plant in central China had been raised to 400 yuan ($54.75) from 100 yuan.

Google pauses enforcement of in-house billing system in India on antitrust directive

Nov 1st, 2022 - BENGALURU, Nov 1 (Reuters) - Alphabet Inc’s Google is pausing its policy that requires app developers to use its Google Play billing system for buying digital goods and services in India, following a ruling by the country’s antitrust body. Google had previously set an extended deadline of Oct. 31 for developers in India to comply with its payments policy. The search engine giant should not rest...

Judge rules that giant U.S. book merger may not go forward

Oct 31st, 2022 - WASHINGTON, Oct 31 (Reuters) - A U.S. judge ruled on Monday that a planned $2.2 billion merger of Penguin Random House, the world’s largest book publisher and owned by German media group Bertelsmann SE & Co, may not merge with rival Simon & Schuster, owned by Paramount Global. (Reporting by Diane Bartz; Editing by Leslie Adler)

Canada's industry minister rejects wholesale merger of Shaw, Rogers

Oct 25th, 2022 - Oct 25 (Reuters) - Canadian Industry Minister François-Philippe Champagne said on Tuesday that the Canada government has rejected the wholesale transfer of the Spectrum license from Shaw Communications to Rogers Communications. (Reporting by Dan Whitcomb and Divya Rajagopal)

No surge expected in global COVID cases this winter - IHME report

Oct 25th, 2022 - Oct 25 (Reuters) - Global COVID-19 infections are projected to rise slowly to about 18.7 million average daily cases by February next year from the current 16.7 million daily driven by the northern hemisphere’s winter months, the University of Washington said in an analysis. The increase in infections is not expected to cause a surge in deaths, the University of Washington’s Institute for Healt...

Argentina changes biofuel pricing in line with surging inflation

Oct 25th, 2022 - BUENOS AIRES, Oct 25 (Reuters) - Argentina’s government has set new criteria for fixing the value of sugar cane- and corn-based bioethanol used in gasoline for domestic consumption, the country’s official gazette said on Tuesday. The measure aims to adjust prices in line with the sharp rise in inflation in the country, which could exceed 100% this year. The ministry of economy’s energy secretar...